Belite Bio BLTE Institutional Ownership

Updated Oct 5, 2026

Belite Bio, Inc (NASDAQ:BLTE) had 82 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Collectively, these holders controlled 28.25% of Belite Bio's outstanding shares in Q2 2026, up from 27.31% in Q1 2026.
• Total holdings of Belite Bio shares rose 3.44% from Q1 2026, and the number of holders rose 412.50% from Q2 2025.
• Looking at the 82 holders of BLTE individually, 51 added to their positions, 22 reduced their stakes and 9 left their positions unchanged.
• Combined, institutional investors held 9.47Mn shares of BLTE as of Q2 2026, up 315.37K from the prior quarter and up 9.4Mn from a year earlier.
• Darwin Global Management, Ltd. led 13F holders of BLTE with 3.08Mn shares as of June 30, 2026, or 9.18% of shares outstanding.
• The largest position increases in BLTE for Q2 2026 were by Citadel Advisors LLC (+184.16K shares), Bank of America Corp (+121K shares), Paradigm Biocapital Advisors LP (+118.09K shares), Affinity Asset Advisors, LLC (+100K shares) and Goldman Sachs Group Inc (+60.68K shares).
• The biggest cuts to BLTE positions during Q2 2026 came from UBS Group AG (-543.37K shares), Holocene Advisors, LP (-243.46K shares), T. Rowe Price Associates Inc (-175.95K shares), Millennium Management LLC (-75.52K shares) and Fred Alger Management, LLC (-60.45K shares).
• Per Business Quant data, the 10 largest holders of Belite Bio at the end of Q2 2026 were Darwin Global Management, Ltd. (3.08Mn shares), Paradigm Biocapital Advisors LP (1.23Mn shares), RTW Investments, LP (715.33K shares), Millennium Management LLC (494.56K shares), Maverick Capital LTD (396.31K shares), Eventide Asset Management, LLC (390.83K shares), Deerfield Management Company, L.P. (357.2K shares), Holocene Advisors, LP (251.03K shares), Logos Global Management LP (250K shares) and Morgan Stanley (235.07K shares).